{'52WeekChange': 0.11020839,
 'SandP52WeekChange': None,
 'address1': 'Jialong International Tower',
 'address2': '18th floor No.19 Chaoyang Park Road Chaoyang District',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 106.63,
 'askSize': 1000,
 'averageDailyVolume10Day': 91975,
 'averageVolume': 105792,
 'averageVolume10days': 91975,
 'beta': 0.576923,
 'beta3Year': None,
 'bid': 105.5,
 'bidSize': 800,
 'bookValue': 45.113,
 'category': None,
 'circulatingSupply': None,
 'city': 'Beijing',
 'companyOfficers': [],
 'country': 'China',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 107.14,
 'dayLow': 104.685,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': 0.416,
 'enterpriseToEbitda': 14.861,
 'enterpriseToRevenue': 5.934,
 'enterpriseValue': 3184113408,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '86 10 6598 3222',
 'fiftyDayAverage': 106.99715,
 'fiftyTwoWeekHigh': 119.44,
 'fiftyTwoWeekLow': 92.22,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 14178939,
 'forwardEps': 5.28,
 'forwardPE': 20.166666,
 'fromCurrency': None,
 'fullTimeEmployees': 2246,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.5417,
 'heldPercentInstitutions': 0.40495,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/chinabiologic.com',
 'longBusinessSummary': 'China Biologic Products Holdings, Inc. engages in the '
                        'research, development, manufacture, and sale of human '
                        'plasma-based biopharmaceutical products to hospitals '
                        "and inoculation centers in the People's Republic of "
                        'China. It offers human albumin for treating shock '
                        'caused by blood loss trauma or burn; raised '
                        'intracranial pressure caused by hydrocephalus or '
                        'trauma; oedema or ascites caused by hepatocirrhosis '
                        'and nephropathy; and neonatal hyperbilirubinemia, as '
                        'well as for the prevention and treatment of '
                        'low-density-lipoproteinemia. The company also '
                        'provides human immunoglobulin and IVIG for original '
                        'and secondary immunoglobulin deficiency, and '
                        'immunoglobulin G secondary deficiency; human '
                        'hepatitis B immunoglobulin for the prevention of '
                        'measles and contagious hepatitis; human rabies '
                        'immunoglobulin primarily for passive immunity from '
                        'bites or claws by rabies or other infected animals; '
                        'and human tetanus immunoglobulin for the prevention '
                        'and therapy of tetanus. In addition, it offers '
                        'placenta polypeptide for the treatment of cell '
                        'immunity deficiency diseases, viral infection, and '
                        'leucopenia, as well as assists in postoperative '
                        'healing; factor VIII for treating coagulopathies; '
                        'human fibrinogen; and human prothrombin complex '
                        'concentrate for treating congenital and acquired '
                        'clotting factor II, VII, IX, X deficiency, as well as '
                        'excessive anticoagulant, vitamin K deficiency, etc. '
                        'Further, the company is developing Human fibrinogen '
                        'for the treatment for lack of fibrinogen and increase '
                        'human fibrinogen concentration; and artificial dura '
                        'and spinal dura mater products for use in brain and '
                        'spinal surgeries. The company sells its products '
                        'directly, as well as through distributors. The '
                        'company was formerly known as China Biologic '
                        'Products, Inc. and changed its name to China Biologic '
                        'Products Holdings, Inc. in July 2017. China Biologic '
                        'Products Holdings, Inc. is headquartered in Beijing, '
                        "the People's Republic of China.",
 'longName': 'China Biologic Products Holdings, Inc.',
 'market': 'us_market',
 'marketCap': 4097414400,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_28240761',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': 152809536,
 'nextFiscalYearEnd': 1640908800,
 'open': 106.5,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 2.35,
 'phone': '86 10 6598 3111',
 'previousClose': 106.58,
 'priceHint': 2,
 'priceToBook': 2.3602953,
 'priceToSalesTrailing12Months': 7.636562,
 'profitMargins': 0.28795,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 107.14,
 'regularMarketDayLow': 104.685,
 'regularMarketOpen': 106.5,
 'regularMarketPreviousClose': 106.58,
 'regularMarketPrice': 106.5,
 'regularMarketVolume': 131993,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 38459800,
 'sharesPercentSharesOut': 0.0116,
 'sharesShort': 448267,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 426334,
 'shortName': 'China Biologic Products Holding',
 'shortPercentOfFloat': 0.0201,
 'shortRatio': 3.24,
 'startDate': None,
 'strikePrice': None,
 'symbol': 'CBPO',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': 3.951,
 'trailingPE': 26.95014,
 'twoHundredDayAverage': 110.276405,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '4919f500-b28b-374d-8dd1-f7ab7f12007a',
 'volume': 131993,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.chinabiologic.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '100125'}